KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bausch Health Companies (BHC) Operating Expenses (2016 - 2026)

Bausch Health Companies' Operating Expenses history spans 18 years, with the latest figure at $3.5 billion for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 75.19% to $3.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $9.9 billion, a 21.42% increase, with the full-year FY2025 number at $8.5 billion, up 4.63% from a year prior.
  • Operating Expenses hit $3.5 billion in Q1 2026 for Bausch Health Companies, up from $2.3 billion in the prior quarter.
  • Over the last five years, Operating Expenses for BHC hit a ceiling of $3.5 billion in Q1 2026 and a floor of $1.6 billion in Q1 2022.
  • Historically, Operating Expenses has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2024.
  • Biggest five-year swings in Operating Expenses: dropped 27.36% in 2022 and later soared 75.19% in 2026.
  • Tracing BHC's Operating Expenses over 5 years: stood at $2.4 billion in 2022, then dropped by 15.77% to $2.0 billion in 2023, then decreased by 2.2% to $2.0 billion in 2024, then rose by 16.04% to $2.3 billion in 2025, then soared by 49.61% to $3.5 billion in 2026.
  • Business Quant data shows Operating Expenses for BHC at $3.5 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.1 billion in Q3 2025.